Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial

Amy C.M. Musiek, Sean Whittaker, Steven M. Horowitz, Martine Bagot, Auris Huen, David C. Fisher, Paul Haun, Maarten H. Vermeer, Takahiro Ito, Karen Dwyer, Fiona Herr, Youn H. Kim

Research output: Contribution to journalArticlepeer-review

5 Scopus citations
Original languageEnglish
Pages (from-to)S46
JournalEuropean Journal of Cancer
Volume156
DOIs
StatePublished - Oct 1 2021

Keywords

  • CTCL
  • MAVORIC
  • Sézary syndrome
  • drug rash
  • mogamulizumab
  • mycosis fungoides

Cite this